WSO December 2023 – Issue 3 - 1204

1204
International Journal of Stroke 18(10)
Figure 2. Comparison of detailed and conventional DWIASPECTS.
The detailed ASPECTS and conventional DWIASPECTS
are 6 and 2, respectively. The white arrows show
the areas of hyperintensity, which were counted using the
detailed ASPECTS. Both white (M3, M6, insular cortex, and
lentiform) and red (M1, M2, M4, and M5) arrows show areas
of hyperintensity, which were counted using conventional
DWI-ASPECTS.
rate. Second, we compared conventional and detailed DWIASPECTS
and calculated the median score. Third, we calculated
the correlation coefficient between the ischemic
core volume and DWI-ASPECTS to determine the best
predictor of the infarct core volume. Fourth, we investigated
the association between the clinical outcomes at
90 days and the two DWI-ASPECTSs. Finally, we divided
patients with conventional DWI-ASPECTS ⩽6 into two
groups according to detailed DWI-ASPECTS ⩽6 or >6.
We then compared the clinical outcomes at 90 days and the
ischemic core volume between the two groups. Welch's and
two-tailed Fisher's tests were used to analyze differences in
continuous and categorical variables, respectively.
Statistical significance was set at a two-tailed P-value of
<0.05. All statistical analyses were performed using the
JMP version 11 software (SAS Institute, Cary, NC, USA).
Results
free open-source extensible software application, built with
support from the National Institutes of Health, for medical
image computing and visualization.16 DWI was obtained
using the following parameters: TR/TE, 6000/65 ms; b-values,
0 and 1000 s/mm2; field of view, 24 cm; acquisition
matrix, 128 × 128; and slice thickness, 4.5 mm with a
2.5 mm intersection gap. The patients' digital images were
imported, and a hyperintense lesion on DWI was semiautomatically
outlined on each slice using segmentation
tools within 3D Slicer. The hyperintense area (cm2) was
multiplied by the slice thickness plus the intersection gap,
resulting in a volume measurement (cm3).
Clinical outcomes
The patients were followed up for 90 days after symptom
onset. A favorable outcome was defined as an mRS score
⩽2 at the 90-day follow-up. The mRS score was assessed
by site personnel via physical examination or telephone
interviews with the patients or their relatives.
Imaging
To examine patients with suspected stroke, MRI was performed
immediately using a 1.5T scanner (ECHELON_
OVAL, Hitachi Medical Corporation, Tokyo, Japan),
including DWI, fluid-attenuated inversion recovery (FLAIR),
magnetic resonance angiography (MRA), and T2* imaging.
Statistical analysis
First, we assessed the patients' backgrounds, neurological
deficits, time from onset, radiological findings, and the IVT
International Journal of Stroke, 18(10)
Of the 448 consecutive patients with AIS who were treated
with EVT, 56 had posterior circulation, 51 had a pre-mRS
score >2, 22 did not undergo MRI before EVT, and 21 had
no infarct volume data owing to low-quality images. After
excluding these patients, 298 (median age, 75 (67-82)
years; 194 (65%) males; median NIHSS score, 15 (9-21))
were enrolled. The onset-to-door time was 150 (55-299)
min, and the door-to-imaging time was 22 (7-32) min. The
occluded vessel sites identified by MRA/CT angiography
were the internal carotid artery in 81 patients (27%), M1 in
128 (43%), M2/M3 in 93 (31%), and A1 in 4 (1%). The
median infarct volume was 11 (3-37) mL. A total of 108
(36%) patients were treated with IVT, and all patients were
treated with EVT (Table 1).
Conventional and detailed DWI-ASPECTS
The number of patients with conventional and detailed
DWI-ASPECTS ⩽6 was 134 (45%) and 73 (24%), respectively.
Therefore, 61 patients (20%) had conventional DWIASPECTS
⩽6 and detailed DWI-ASPECTS >6. The
detailed DWI-ASPECTS was significantly higher than the
conventional DWI-ASPECTS (8 (7-9) vs. 7 (5-9),
P < 0.01; Figure 3).
Next, we calculated the correlation coefficient (r)
between the ischemic core volume and both conventional
DWI-ASPECTS and detailed DWI-ASPECTS. The coefficient
was higher for detailed DWI-ASPECTS (r = 0.832,
P < 0.01) than for conventional DWI-ASPECTS (r = 0.773,
P < 0.01; Figure 4).
Clinical outcome according to
DWI-ASPECTS
Among 298 patients, 146 (49%) and 152 (51%) had favorable
and poor outcomes, respectively. Of the patients with

WSO December 2023 – Issue 3

Table of Contents for the Digital Edition of WSO December 2023 – Issue 3

Contents
WSO December 2023 – Issue 3 - Cover1
WSO December 2023 – Issue 3 - Cover2
WSO December 2023 – Issue 3 - 1143
WSO December 2023 – Issue 3 - Contents
WSO December 2023 – Issue 3 - 1145
WSO December 2023 – Issue 3 - 1146
WSO December 2023 – Issue 3 - 1147
WSO December 2023 – Issue 3 - 1148
WSO December 2023 – Issue 3 - 1149
WSO December 2023 – Issue 3 - 1150
WSO December 2023 – Issue 3 - 1151
WSO December 2023 – Issue 3 - 1152
WSO December 2023 – Issue 3 - 1153
WSO December 2023 – Issue 3 - 1154
WSO December 2023 – Issue 3 - 1155
WSO December 2023 – Issue 3 - 1156
WSO December 2023 – Issue 3 - 1157
WSO December 2023 – Issue 3 - 1158
WSO December 2023 – Issue 3 - 1159
WSO December 2023 – Issue 3 - 1160
WSO December 2023 – Issue 3 - 1161
WSO December 2023 – Issue 3 - 1162
WSO December 2023 – Issue 3 - 1163
WSO December 2023 – Issue 3 - 1164
WSO December 2023 – Issue 3 - 1165
WSO December 2023 – Issue 3 - 1166
WSO December 2023 – Issue 3 - 1167
WSO December 2023 – Issue 3 - 1168
WSO December 2023 – Issue 3 - 1169
WSO December 2023 – Issue 3 - 1170
WSO December 2023 – Issue 3 - 1171
WSO December 2023 – Issue 3 - 1172
WSO December 2023 – Issue 3 - 1173
WSO December 2023 – Issue 3 - 1174
WSO December 2023 – Issue 3 - 1175
WSO December 2023 – Issue 3 - 1176
WSO December 2023 – Issue 3 - 1177
WSO December 2023 – Issue 3 - 1178
WSO December 2023 – Issue 3 - 1179
WSO December 2023 – Issue 3 - 1180
WSO December 2023 – Issue 3 - 1181
WSO December 2023 – Issue 3 - 1182
WSO December 2023 – Issue 3 - 1183
WSO December 2023 – Issue 3 - 1184
WSO December 2023 – Issue 3 - 1185
WSO December 2023 – Issue 3 - 1186
WSO December 2023 – Issue 3 - 1187
WSO December 2023 – Issue 3 - 1188
WSO December 2023 – Issue 3 - 1189
WSO December 2023 – Issue 3 - 1190
WSO December 2023 – Issue 3 - 1191
WSO December 2023 – Issue 3 - 1192
WSO December 2023 – Issue 3 - 1193
WSO December 2023 – Issue 3 - 1194
WSO December 2023 – Issue 3 - 1195
WSO December 2023 – Issue 3 - 1196
WSO December 2023 – Issue 3 - 1197
WSO December 2023 – Issue 3 - 1198
WSO December 2023 – Issue 3 - 1199
WSO December 2023 – Issue 3 - 1200
WSO December 2023 – Issue 3 - 1201
WSO December 2023 – Issue 3 - 1202
WSO December 2023 – Issue 3 - 1203
WSO December 2023 – Issue 3 - 1204
WSO December 2023 – Issue 3 - 1205
WSO December 2023 – Issue 3 - 1206
WSO December 2023 – Issue 3 - 1207
WSO December 2023 – Issue 3 - 1208
WSO December 2023 – Issue 3 - 1209
WSO December 2023 – Issue 3 - 1210
WSO December 2023 – Issue 3 - 1211
WSO December 2023 – Issue 3 - 1212
WSO December 2023 – Issue 3 - 1213
WSO December 2023 – Issue 3 - 1214
WSO December 2023 – Issue 3 - 1215
WSO December 2023 – Issue 3 - 1216
WSO December 2023 – Issue 3 - 1217
WSO December 2023 – Issue 3 - 1218
WSO December 2023 – Issue 3 - 1219
WSO December 2023 – Issue 3 - 1220
WSO December 2023 – Issue 3 - 1221
WSO December 2023 – Issue 3 - 1222
WSO December 2023 – Issue 3 - 1223
WSO December 2023 – Issue 3 - 1224
WSO December 2023 – Issue 3 - 1225
WSO December 2023 – Issue 3 - 1226
WSO December 2023 – Issue 3 - 1227
WSO December 2023 – Issue 3 - 1228
WSO December 2023 – Issue 3 - 1229
WSO December 2023 – Issue 3 - 1230
WSO December 2023 – Issue 3 - 1231
WSO December 2023 – Issue 3 - 1232
WSO December 2023 – Issue 3 - 1233
WSO December 2023 – Issue 3 - 1234
WSO December 2023 – Issue 3 - 1235
WSO December 2023 – Issue 3 - 1236
WSO December 2023 – Issue 3 - 1237
WSO December 2023 – Issue 3 - 1238
WSO December 2023 – Issue 3 - 1239
WSO December 2023 – Issue 3 - 1240
WSO December 2023 – Issue 3 - 1241
WSO December 2023 – Issue 3 - 1242
WSO December 2023 – Issue 3 - 1243
WSO December 2023 – Issue 3 - 1244
WSO December 2023 – Issue 3 - 1245
WSO December 2023 – Issue 3 - 1246
WSO December 2023 – Issue 3 - 1247
WSO December 2023 – Issue 3 - 1248
WSO December 2023 – Issue 3 - 1249
WSO December 2023 – Issue 3 - 1250
WSO December 2023 – Issue 3 - 1251
WSO December 2023 – Issue 3 - 1252
WSO December 2023 – Issue 3 - 1253
WSO December 2023 – Issue 3 - 1254
WSO December 2023 – Issue 3 - 1255
WSO December 2023 – Issue 3 - 1256
WSO December 2023 – Issue 3 - 1257
WSO December 2023 – Issue 3 - 1258
WSO December 2023 – Issue 3 - 1259
WSO December 2023 – Issue 3 - 1260
WSO December 2023 – Issue 3 - Cover3
WSO December 2023 – Issue 3 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com